Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -9.69% is 82% above its 5-year average of -53.69%, near the high end of its 5-year range (-103.36%–-9.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.23% above its 12-month average of -21.64%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -9.69%.
RETURN ON EQUITY (ROE)
-9.69%
RETURN ON EQUITY (ROE) AVG TTM
-21.64%
RETURN ON EQUITY (ROE) AVG 3Y
-46.45%
RETURN ON EQUITY (ROE) AVG 5Y
-53.69%
RETURN ON EQUITY (ROE) AVG 10Y
-64.68%
RETURN ON EQUITY (ROE) AVG 15Y
-69.71%
RETURN ON EQUITY (ROE) AVG 20Y
-75.46%
CURRENT VS TTM AVG
+55.23%
CURRENT VS 3Y AVG
+79.15%
CURRENT VS 5Y AVG
+81.96%
CURRENT VS 10Y AVG
+85.02%
CURRENT VS 15Y AVG
+86.10%
CURRENT VS 20Y AVG
+87.16%
SECTOR MEDIAN · HEALTHCARE
-40.75%
median of 681 covered companies
CURRENT VS SECTOR MEDIAN
+76.23%
vs the sector median at left
Cerus Corporation
Market Cap
$474.59M
Return on Equity (ROE)
-9.69%
TTM Avg
-21.64%
3Y Avg
-46.45%
5Y Avg
-53.69%
Market Cap
$477.35M
Return on Equity (ROE)
1.65%
TTM Avg
-27.02%
3Y Avg
-39.92%
5Y Avg
-33.78%
Market Cap
$470.79M
Return on Equity (ROE)
8.25%
TTM Avg
6.54%
3Y Avg
3.79%
5Y Avg
3.91%
Market Cap
$472.23M
Return on Equity (ROE)
-8.21%
TTM Avg
-32.76%
3Y Avg
-79.80%
5Y Avg
-71.61%
Market Cap
$468.38M
Return on Equity (ROE)
-24.02%
TTM Avg
-22.16%
3Y Avg
-34.88%
5Y Avg
-37.32%
Market Cap
$468.47M
Return on Equity (ROE)
-56.26%
TTM Avg
-59.48%
3Y Avg
-54.76%
5Y Avg
-34.52%
Market Cap
$486.60M
Return on Equity (ROE)
19.28%
TTM Avg
28.37%
3Y Avg
24.29%
5Y Avg
382.68%
Market Cap
$460.20M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$488.97M
Return on Equity (ROE)
N/A
TTM Avg
-344.79%
3Y Avg
-198.42%
5Y Avg
-104.57%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $474.59M | -9.69% | -21.64% | -46.45% | -53.69% |
| Arvinas, Inc. (ARVN)vs › | $477.35M | 1.65% | -27.02% | -39.92% | -33.78% |
| Kamada Ltd. (KMDA)vs › | $470.79M | 8.25% | 6.54% | 3.79% | 3.91% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | -8.21% | -32.76% | -79.80% | -71.61% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $468.38M | -24.02% | -22.16% | -34.88% | -37.32% |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | -56.26% | -59.48% | -54.76% | -34.52% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 19.28% | 28.37% | 24.29% | 382.68% |
| NRC Health (NRC)vs › | $460.20M | 89.43% | 81.07% | 67.39% | 61.90% |
| Evolus, Inc. (EOLS)vs › | $488.97M | N/A | -344.79% | -198.42% | -104.57% |
| Oculis Holding AG (OCS)vs › | $494.48M | -36.79% | -82.52% | -55.07% | -25.96% |
ROE
-9.7%
ROA
-3.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -9.69% |
| 2026-03-31 | -14.14% |
| 2025-12-31 | -24.33% |
| 2025-09-30 | -25.97% |
| 2025-06-30 | -34.06% |
| 2025-03-31 | -34.14% |
| 2024-12-31 | -37.26% |
| 2024-09-30 | -36.88% |
| 2024-06-30 | -48.59% |
| 2024-03-31 | -63.92% |
| 2023-12-31 | -71.20% |
| 2023-09-30 | -103.36% |
| 2023-06-30 | -100.36% |
| 2023-03-31 | -78.65% |
| 2022-12-31 | -63.27% |
| 2022-09-30 | -52.34% |
| 2022-06-30 | -55.73% |
| 2022-03-31 | -61.96% |
| 2021-12-31 | -64.26% |
| 2021-09-30 | -74.48% |
| 2021-06-30 | -72.82% |
| 2021-03-31 | -65.69% |
| 2020-12-31 | -57.66% |
| 2020-09-30 | -57.12% |
| 2020-06-30 | -57.83% |
| 2020-03-31 | -61.31% |
| 2019-12-31 | -124.88% |
| 2019-09-30 | -115.98% |
| 2019-06-30 | -101.70% |
| 2019-03-31 | -89.89% |
| 2018-12-31 | -68.11% |
| 2018-09-30 | -57.56% |
| 2018-06-30 | -57.57% |
| 2018-03-31 | -65.27% |
| 2017-12-31 | -155.59% |
| 2017-09-30 | -168.36% |
| 2017-06-30 | -161.76% |
| 2017-03-31 | -155.81% |
| 2016-12-31 | -108.86% |
| 2016-09-30 | -88.73% |
| 2016-06-30 | -87.71% |
| 2016-03-31 | -75.74% |
| 2015-12-31 | -58.95% |
| 2015-09-30 | -63.97% |
| 2015-06-30 | -50.83% |
| 2015-03-31 | -43.48% |
| 2014-12-31 | -92.46% |
| 2014-09-30 | -51.68% |
| 2014-06-30 | -77.31% |
| 2014-03-31 | -74.24% |
| 2013-12-31 | -101.27% |
| 2013-09-30 | -109.95% |
| 2013-06-30 | -40.32% |
| 2013-03-31 | -28.52% |
| 2012-12-31 | -83.30% |
| 2012-09-30 | -131.22% |
| 2012-06-30 | -88.98% |
| 2012-03-31 | -108.16% |
| 2011-12-31 | -93.16% |
| 2011-09-30 | -72.32% |
| 2011-06-30 | -134.28% |
| 2011-03-31 | -88.39% |
| 2010-12-31 | -71.26% |
| 2010-09-30 | -155.75% |
| 2010-06-30 | -173.66% |
| 2010-03-31 | -128.09% |
| 2009-12-31 | -112.53% |
| 2009-09-30 | -97.68% |
| 2009-06-30 | -131.55% |
| 2009-03-31 | -114.34% |
| 2008-12-31 | -85.13% |
| 2008-09-30 | -87.45% |
| 2008-06-30 | -73.13% |
| 2008-03-31 | -78.18% |
| 2007-12-31 | -75.65% |
| 2007-09-30 | -44.63% |
| 2007-06-30 | -30.28% |
| 2007-03-31 | -11.22% |
| 2006-12-31 | -4.73% |
| 2006-09-30 | -15.97% |
| 2006-06-30 | -15.60% |
| 2006-03-31 | -11.83% |
| 2005-12-31 | 37.03% |
| 2005-09-30 | 29.94% |
| 2005-06-30 | 20.36% |
| 2005-03-31 | -1.34% |
| 2004-12-31 | -144.97% |
| 2004-09-30 | -133.08% |
| 2004-06-30 | -140.94% |
| 2004-03-31 | -115.73% |
| 2003-12-31 | -110.93% |
| 2003-09-30 | -101.94% |
| 2003-06-30 | -86.58% |
